問題 › コストが価格を上回るペースで上昇しています › 会計・アドバイザリー事務所
会計事務所のコスト圧迫は、請求単価の問題であると同時に、案件範囲設定の問題でもあります。 会計事務所特有の制約として、コンプライアンス報酬の圧縮と、アドバイザリーへの時間移行が法定業務の縮小を伴う点があります。これが価格設定されない限り、82%という実現率は理由なく低下し続け、人件費転嫁の議論は意見の域を出ません。
会計事務所のコスト圧迫は、請求単価の問題であると同時に、案件範囲設定の問題でもあります。 会計事務所特有の制約として、コンプライアンス報酬の圧縮と、アドバイザリーへの時間移行が法定業務の縮小を伴う点があります。これが価格設定されない限り、82%という実現率は理由なく低下し続け、人件費転嫁の議論は意見の域を出ません。
人件費が報酬を上回る速度で上昇すると、まず請求時間を削減するか稼働率を高めようとします。これは一時的には有効ですが限界があります。時間を削減できるのは一度限りであり、コンプライアンス業務は依然として遂行しなければならず、アドバイザリーを拡大するには法定業務を圧迫することになります。
持続的な対応は構造的なものです。年次交渉ではなく公表指数に連動した報酬条件、短期間のアドバイザリー契約書、帳簿全体ではなく更新時に再価格設定、バンドル内容の変更により前年比で比較されないアドバイザリーサービスに料金改定を集中させる、といった方法です。
もう半分は構成です。大半の事務所では圧迫が一様ではなく、コンプライアンス業務がコスト圧力を吸収し、アドバイザリー業務はより容易に転嫁できるため、請求時間をアドバイザリーへ移行する方が、コンプライアンス案件での料金交渉より通常は速やかです。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 実現率が低下している一方で、請求時間は横ばいです。
✓ 料金改定のたびに、毎回クライアントとの新規交渉が必要です。
✓ 契約書に人件費上昇時の料金調整条項がありません。
通常、事態を悪化させる対応です。 コンプライアンス業務量を守るために人件費上昇を吸収し、クライアントに翌年も同額を期待させる結果となり、結局の是正がより大きくなります。
It is for you if you run or finance an accounting firm and gross margin is falling while volumes hold. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 会計事務所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Competitive Positioning · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to コストと粗利の改善, one of 29 engagements the platform runs. For 会計事務所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
外部の検証可能な指標に連動させ、事前に通知することです。公表指数に基づく上昇は事実として受け止められやすく、自社コストを理由とする上昇は交渉を招きやすくなります。
信頼できる指数が存在する場合、年次の議論を排除でき、通常は最初のサイクルで元が取れます。顧客が中立と受け入れる指数を選ぶことが作業です。
更新時に着手し、その間は構成と提供コストに注力します。同時に契約を修正する機会でもあります。同じ圧迫は再び発生するためです。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית